1. Home
  2. AREN vs DYAI Comparison

AREN vs DYAI Comparison

Compare AREN & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AREN
  • DYAI
  • Stock Information
  • Founded
  • AREN 2016
  • DYAI 1979
  • Country
  • AREN United States
  • DYAI United States
  • Employees
  • AREN N/A
  • DYAI N/A
  • Industry
  • AREN Medical/Dental Instruments
  • DYAI Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • AREN Health Care
  • DYAI Health Care
  • Exchange
  • AREN Nasdaq
  • DYAI Nasdaq
  • Market Cap
  • AREN 64.1M
  • DYAI 54.4M
  • IPO Year
  • AREN N/A
  • DYAI 2004
  • Fundamental
  • Price
  • AREN $1.84
  • DYAI $1.38
  • Analyst Decision
  • AREN
  • DYAI Strong Buy
  • Analyst Count
  • AREN 0
  • DYAI 1
  • Target Price
  • AREN N/A
  • DYAI $6.00
  • AVG Volume (30 Days)
  • AREN 28.2K
  • DYAI 59.9K
  • Earning Date
  • AREN 05-16-2025
  • DYAI 03-26-2025
  • Dividend Yield
  • AREN N/A
  • DYAI N/A
  • EPS Growth
  • AREN N/A
  • DYAI N/A
  • EPS
  • AREN N/A
  • DYAI N/A
  • Revenue
  • AREN $234,396,000.00
  • DYAI $3,495,389.00
  • Revenue This Year
  • AREN $12.73
  • DYAI $51.30
  • Revenue Next Year
  • AREN $71.95
  • DYAI $73.26
  • P/E Ratio
  • AREN N/A
  • DYAI N/A
  • Revenue Growth
  • AREN 45.45
  • DYAI 20.58
  • 52 Week Low
  • AREN $0.56
  • DYAI $0.93
  • 52 Week High
  • AREN $2.18
  • DYAI $2.67
  • Technical
  • Relative Strength Index (RSI)
  • AREN 65.73
  • DYAI 46.47
  • Support Level
  • AREN $1.46
  • DYAI $1.29
  • Resistance Level
  • AREN $1.72
  • DYAI $1.45
  • Average True Range (ATR)
  • AREN 0.12
  • DYAI 0.10
  • MACD
  • AREN 0.02
  • DYAI 0.00
  • Stochastic Oscillator
  • AREN 93.23
  • DYAI 41.38

About AREN The Arena Group Holdings Inc.

The Arena Group Holdings Inc is a tech-powered media company that fuses technology, iconic brands, and marketing to deliver vibrant content and experiences that reach million users each month. The company creates robust digital destinations that delight consumers with powerful journalism, news about the things such as favorite sports teams, advice on investing, the inside scoop on personal finance, and the latest on lifestyle essentials. The Company operates in one reportable segment which focuses on a publishing platform. The company generates revenue from Digital and Print, where the majority is generated from Digital. The company owns and operates TheStreet, The Spun, Parade, and Men's Journal and powers more than 320 independent Publisher Partners.

About DYAI Dyadic International Inc.

Dyadic International Inc is a world-wide biotechnology platform company. The company has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins, and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

Share on Social Networks: